Malaria Vaccine Disappoints Researchers

MalariaResearchers have declared the results of the examination of malaria vaccine, developed by GlaxoSmithKline and called RTS, to be disappointing. They suggested that the effect of the vaccine gradually decreases and vanishes after a period of time.

The researchers suggested that the effect of the vaccine disappeared in children, who are most exposed to mosquito bites, at the fastest rate. Records suggested that about 650,000 children lose their lives because of the disease.

The effect of the vaccine was declared as not up to the mark by the researchers. They suggested that it will take a lot of efforts to make the vaccine efficient in fighting the disease.

A large-scale trial of the vaccine was done the previous year. The vaccine was able to save only one-third of the total children from six to 12 years. Gates, co-founder of the Bill & Melinda Gates Foundation and one of the research funders, said the vaccine dashed their hopes and was found to be lesser capable than expected.

The results discovered by the researchers are published in the New England Journal of Medicine. The results included the phase-II of the trial that was conducted on a smaller scale. It included 447 children from Kilifi, Kenya.

The study discovered that the results of the vaccines saw a downfall of 43.6% of its protection in the very first year. The researchers suggested that it had not prevented many cases of malaria in the observatory years.